SCHEMBL3148071

SCHEMBL3148071

CC1(C)CCCC(c2ccc(O)cc2)C1

nearest known ligand 0.56

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 18/20 0.56
TRPA1 O75762 1/20 0.51
ESR1 P03372 9/20 0.49
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18257873 0.86 ESR2 (0.66) ESR2ESR1CYP3A4CYP2D6CYP2C9
SCHEMBL22299932 0.84 TRPA1 (0.49) ESR2TRPA1
SCHEMBL30074982 0.82 TRPA1 (0.47) ESR2TRPA1
SCHEMBL16788269 0.81 ESR2 (0.51) ESR2TRPA1ESR1CYP3A4CYP2D6
SCHEMBL6139859 0.80 TRPA1 (0.46) ESR2TRPA1
SCHEMBL7640447 0.78 ESR2 (0.47) ESR2TRPA1ESR1CYP3A4CYP2D6
SCHEMBL18257845 0.77 ESR2 (0.86) ESR2TRPA1ESR1CYP3A4CYP2D6
SCHEMBL18257842 0.77 ESR2 (0.86) ESR2TRPA1ESR1CYP3A4CYP2D6
SCHEMBL16581404 0.77 ESR2 (0.55) ESR2TRPA1ESR1CYP3A4CYP2D6
SCHEMBL3148250 0.77 ESR2 (0.75) ESR2ESR1CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114302905-A Thermoplastic resin composition and molded article 三菱化学株式会社 2022-04-08 CN disclosed
WO-2021039970-A1 THERMOPLASTIC RESIN COMPOSITION AND MOLDED ARTICLE 三菱ケミカル株式会社 2021-03-04 WO disclosed
EP-2137193-B1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI SA (FR) 2017-08-09 EP disclosed
CN-105431488-B Thin walled optical component poly carbonate resin composition and thin walled optical component 三菱工程塑料株式会社 2017-06-13 CN disclosed
CN-104447792-A Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI AVENTIS 2015-03-25 CN disclosed
US-8642603-B2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI (FR) 2014-02-04 US disclosed
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2010-03-25 US disclosed
EP-2137193-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF Sanofi-Aventis (FR) 2009-12-30 EP disclosed
WO-2008112483-A2 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2008-09-18 WO disclosed
EP-1927098-A2 ILLUMINATING DEVICE COMBINING A WHITE LED AND A DIFFUSING SHEET ARKEMA France (FR) 2008-06-04 EP disclosed
EP-1864274-A2 ILLUMINATING DEVICE COMBINING A LED AND A DIFFUSING SHEET ARKEMA FRANCE (FR) 2007-12-12 EP disclosed
WO-2006100126-A2 ILLUMINATING DEVICE COMBINING A LED AND A DIFFUSING SHEET ARKEMA FRANCE (FR) 2006-09-28 WO disclosed
WO-2006100127-A2 ILLUMINATING DEVICE COMBINING A WHITE LED AND A DIFFUSING SHEET ARKEMA FRANCE (FR) 2006-09-28 WO disclosed
CN-1116333-C Process for producing polycarbonate BAYER AG (DE) 2003-07-30 CN disclosed
CN-1412247-A Flame-retarded synthetic resin composition ASAHI DENKA KOGYO KK (JP) 2003-04-23 CN disclosed
CN-1261903-A Process for producing polycarbonate BAYER AG (DE) 2000-08-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF GRM2, GRM1, GRIN2C ESR2 491/4885TRPA1 302/4885ESR1 699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.